MOLECUBES published a study by Gash, E.N. and colleagues at the University of Liverpool investigating hypoxia-driven vascular remodeling and glycolytic shift in glioblastoma xenografts in the chick chorioallantoic membrane model.
Published
Signal category
Research & Knowledge
Quote
“This study from Gash, E.N. and colleagues at the University of Liverpool investigated the hypoxia-driven vascular remodeling and glycolytic shift in glioblastoma (GBM) xenografts in the CAM model.”
— MOLECUBES team
Company
MOLECUBES
Making molecular imaging available to anyone.
- Industry
- Biotechnology
- Location
- Ghent, BE
- Company size
- 16 employees
At MOLECUBES, we believe that molecular imaging should be accessible to every research lab. It is therefore our mission to lower the barrier to preclinical PET, SPECT and CT imaging by providing compact, intuitive, flexible benchtop imaging solutions with the highest performance, supported by fast and simple workflows. With more than 100 CUBES installed worldwide, MOLECUBES is a trusted partner by your side. At MOLECUBES we provide three separate benchtop imagers or “CUBES”: The γ-CUBE is our high-resolution, high-sensitivity micro-SPECT scanner using patented collimator design. The X-CUBE is our high-throughput micro-CT scanner allowing sub-minute acquisition at extremely low doses. The β-CUBE is our sub-millimeter, high-sensitivity whole body mouse and rat micro-PET scanner. www.molecubes.com
Founded 2015